Plus: NIH begins review of delayed research proposals, funding 135 on first day

December 31, 2025 Check out STAT+

Sponsored By

Jeff Pinette for STAT The top medical advances of 2025 New drugs reshaped care for HIV, obesity, lung cancer, and more in 2025. Prepare to hear more about drugs such as Yeztugo, Nuzolvence, Tagrisso and Enhertu. By Matthew Herper NIH begins review of thousands of delayed research proposals, funding 135 on first day Hundreds of delayed research proposals earn a review on their merits, but still must survive NIH review for alignment with Trump priorities By Anil Oza Opinion: The most-read First Opinion essays of 2025 In 2025, STAT readers devoured op-eds on vaccines, MAHA, AI, health insurance, and other crucial topics. By Torie Bosch

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser